The Size of the Gastric Remnant as Determinant for Delayed Gastric Emptying After Whipple Resection.

NCT ID: NCT02041052

Last Updated: 2017-01-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE2

Total Enrollment

7 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-01-31

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A small gastric remnant after whipple resection improves gastric emptying and therefore prevents the development of delayed gastric emptying.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Every patient submitted to a whipple resection and at the same time present with characteristics suggestive of minimal risk for leakage from the pancreaticojejunostomy will be included in the study. At the time of reconstruction the patient will be randomized to either conventional size of the stomach or to a subtotal gastrectomy containing a small upper gastric pouch only.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

50 % Reduction of Delayed Gastric Emptying

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conventional Whipple procedure

Conventional Whipple procedure

Group Type ACTIVE_COMPARATOR

Conventional whipple procedure

Intervention Type PROCEDURE

All patients undergoing whipple procedure without risk for pancreaticojejunal anastomosis leakage.

Subtotal gastrectomy added to whipple procedure.

Subtotal gastrectomy added to Whipple procedure.

Group Type EXPERIMENTAL

Subtotal gastrectomy as an adjunct to traditional whipple procedure.

Intervention Type PROCEDURE

Subtotal gastrectomy as an adjunct to traditional whipple procedure.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Subtotal gastrectomy as an adjunct to traditional whipple procedure.

Subtotal gastrectomy as an adjunct to traditional whipple procedure.

Intervention Type PROCEDURE

Conventional whipple procedure

All patients undergoing whipple procedure without risk for pancreaticojejunal anastomosis leakage.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

All patients undergoing whipple procedure with preoperative assignment as low risk for leakage from the pancreaticojejunal anastomosis.

* Signed informed consent.

Exclusion Criteria

* High and intermediate risk pancreaticojejunal anastomosis. Unwillingness to participate.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ralf Segersvärd

UNKNOWN

Sponsor Role collaborator

Afshin Noorani

UNKNOWN

Sponsor Role collaborator

John Blomberg

UNKNOWN

Sponsor Role collaborator

Karolinska University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lars Lundell

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lars Lundell, professor

Role: PRINCIPAL_INVESTIGATOR

Karolinska University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Karolinska University Hospital Gastrocentrum

Stockholm, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011/1262-31/3

Identifier Type: OTHER

Identifier Source: secondary_id

2011/1262-31/3

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.